We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSA icon
376
Public Storage
PSA
$60.6B
$2.94M 0.05%
14,545
-140
-1% -$28.6K
KHC icon
377
Kraft Heinz
KHC
$31.2B
$2.91M 0.04%
67,513
+5,230
+8% +$271K
IFF icon
378
International Flavors & Fragrances
IFF
$19.6B
$2.89M 0.04%
21,526
-2,035
-9% -$282K
PEG icon
379
Public Service Enterprise Group
PEG
$39.4B
$2.87M 0.04%
55,187
+18,581
+51% +$1M
TGTX icon
380
TG Therapeutics
TGTX
$8.54B
$2.84M 0.04%
692,000
– –
INDA icon
381
iShares MSCI India ETF
INDA
$6.75B
$2.83M 0.04%
85,000
+5,000
+6% +$158K
DINO icon
382
HF Sinclair
DINO
$16.2B
$2.82M 0.04%
55,228
+40,984
+288% +$2.51M
ACAD icon
383
Acadia Pharmaceuticals
ACAD
$4.36B
$2.81M 0.04%
173,700
+38,000
+28% +$738K
GDDY icon
384
GoDaddy
GDDY
$13B
$2.8M 0.04%
+42,693
New +$2.92M
SIX
385
DELISTED
Six Flags Entertainment Corp.
SIX
$2.79M 0.04%
+50,234
New +$3M
IP icon
386
International Paper
IP
$22.4B
$2.79M 0.04%
72,998
-4,504
-6% -$189K
GWW icon
387
W.W. Grainger
GWW
$65.4B
$2.79M 0.04%
9,872
+2,877
+41% +$856K
CTSH icon
388
Cognizant
CTSH
$22.5B
$2.75M 0.04%
43,305
-918
-2% -$63.9K
Z icon
389
Zillow
Z
$7.47B
$2.75M 0.04%
86,955
-58,039
-40% -$2.06M
RSG icon
390
Republic Services
RSG
$67.2B
$2.72M 0.04%
37,775
+7,544
+25% +$552K
HST icon
391
Host Hotels & Resorts
HST
$17B
$2.7M 0.04%
162,179
-164,629
-50% -$3.08M
LUMN icon
392
Lumen
LUMN
$6.32B
$2.69M 0.04%
177,444
+32,211
+22% +$615K
LRMR icon
393
Larimar Therapeutics
LRMR
$398M
$2.67M 0.04%
44,917
+3,584
+9% +$354K
ENB icon
394
Enbridge
ENB
$121B
$2.66M 0.04%
85,779
+97
+0.1% +$3.12K
NXTM
395
DELISTED
NxStage Medical Inc.
NXTM
$2.66M 0.04%
92,842
– –
SBAC icon
396
SBA Communications
SBAC
$18.4B
$2.64M 0.04%
16,311
-691
-4% -$112K
ETR icon
397
Entergy
ETR
$53.1B
$2.63M 0.04%
61,146
+9,706
+19% +$413K
TYL icon
398
Tyler Technologies
TYL
$13.2B
$2.62M 0.04%
+14,115
New +$2.79M
MDCO
399
DELISTED
Medicines Co
MDCO
$2.61M 0.04%
136,500
– –
NUE icon
400
Nucor
NUE
$56B
$2.55M 0.04%
49,210
-1,889
-4% -$112K
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.